Poor aspirin response in diabetic patients presenting with acute coronary syndromes: Results using a near patient test

Thrombosis Research

Volumn 128, Issue 2, 2011, Pages 196-199

  Amoah, V ^a   Smallwood, A ^a   Worrall, A P ^a   Lovatt, T ^a   Armesilla, A L ^b   Nevill, A M ^b   Cotton, J M ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GENOMIC DNA;

ACUTE CORONARY SYNDROME; ADULT; AGED; DIABETES MELLITUS; DIABETIC PATIENT; DNA ISOLATION; DRUG EFFECT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ASPIRIN; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 79960432150     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.04.003     Document Type: Letter

References (29)

1. S.B. Mortensen, S.B. Larsen, E.L. Grove, S.D. Kristensen, and A.M. Hvas Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus Thromb Res 126 4 2010 Oct e318 e322
2. D.J. Fitzgerald, L. Roy, F. Catella, and G.A. FitzGerald Platelet activation in unstable coronary disease N Engl J Med 315 1986 983 989 (Pubitemid 16028578)
3. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (1) N Engl J Med 326 1992 242 250
4. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
5. B.F. McAdam, F. Catella-Lawson, I.A. Mardini, S. Kapoor, J.A. Lawson, and G.A. FitzGerald Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 Proc Natl Acad Sci U S A 96 1999 272 277 (Pubitemid 29036089)
6. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431 (Pubitemid 28405191)
7. J.B. Buse, H.N. Ginsberg, G.L. Bakris, N.G. Clark, F. Costa, and R. Eckel Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Diabetes Care 30 2007 162 172 (Pubitemid 46052519)
8. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
9. J.F. Mustard, and M.A. Packham Platelets and diabetes mellitus N Engl J Med 297 1977 1345 1347 (Pubitemid 8249127)
10. E.L. Grove, A.M. Hvas, S.B. Larsen, S.B. Mortensen, and S.D. Kristensen Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: reply to a rebuttal J Thromb Haemost 9 4 2011 Apr 889 890
11. E.L. Grove, A.M. Hvas, and S.D. Kristensen Immature platelets in patients with acute coronary syndromes Thromb Haemost 101 2009 151 156
12. G. Davi, I. Catalano, M. Averna, A. Notarbartolo, A. Strano, and G. Ciabattani Thromboxane biosynthesis and platelet function in type II diabetes mellitus N Engl J Med 322 1990 1769 1774 (Pubitemid 20194655)
13. J.E. Reusch Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J Clin Invest 112 2003 986 988 (Pubitemid 38056313)
14. M. Friend, I. Vucenik, and M. Miller Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia BMJ 326 2003 82 83 (Pubitemid 36092290)
15. T. Cuisset, C. Frere, J. Quilici, B. Gaborit, L. Bali, and R. Poyet Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting Am Heart J 157 2009 889 893
16. F. Catella-Lawson, M.P. Reilly, S.C. Kapoor, A.J. Cucchiara, S. DeMarco, and B. Tournier Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 2001 1809 1817
17. A.O. Maree, R.J. Curtin, A. Chubb, C. Dolan, D. Cox, and J. O'Brien Cyclooxygenase-1 haplotype modulates platelet response to aspirin J Thromb Haemost 3 2005 2340 2345 (Pubitemid 41727215)
18. G.E. Cooke, P.F. Bray, J.D. Hamlington, D.M. Pham, and P.J. Goldschmidt-Clermont PlA2 polymorphism and efficacy of aspirin Lancet 351 1998 1253
19. E. Papp, V. Havasi, J. Bene, K. Komlosi, L. Czopf, and E. Magyar Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation? Ann Pharmacother 39 2005 1013 1018 (Pubitemid 40695965)
20. A. Undas, M. Sanak, J. Musial, and A. Szczeklik Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation Lancet 353 1999 982 983 (Pubitemid 29132613)
21. VerifyNow Aspirin instructions for use 2010 Ref Type: Generic
22. P.M. Ridker, J.E. Buring, and N. Rifai Soluble P-selectin and the risk of future cardiovascular events Circulation 103 2001 491 495 (Pubitemid 32116231)
23. A. Mathur, M.S. Robinson, J. Cotton, J.F. Martin, and J.D. Erusalimsky Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction Thromb Haemost 85 2001 989 994 (Pubitemid 32573748)
24. J. Dawson, T. Quinn, M. Rafferty, P. Higgins, G. Ray, and K.R. Lees Aspirin Resistance and Compliance with Therapy Cardiovasc Ther 2010 June 11, doi:10.1111/j.1755-5922.2010.00188.x
25. P.Y. Lee, W.H. Chen, W. Ng, X. Cheng, J.Y. Kwok, and H.F. Tse Low-dose aspirin increases aspirin resistance in patients with coronary artery disease Am J Med 118 2005 723 727 (Pubitemid 40897657)
26. T. Cuisset, C. Frere, J. Quilici, P.E. Morange, J.P. Mouret, and L. Bali Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study JACC Cardiovasc Interv 1 2008 649 653
27. M. Valgimigli, G. Campo, N. de Cesare, E. Meliga, P. Vranckx, and A. Furgieri Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study Circulation 119 2009 3215 3222
28. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, and C.H. McGabe Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
29. L.L. De, P.G. De, M. Minati, C. Iacoboni, and F. Fedele Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting Am Heart J 149 2005 1135